MedPath

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Phase 3
Completed
Conditions
Epilepsy
Interventions
Registration Number
NCT00530855
Lead Sponsor
UCB Pharma
Brief Summary

This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the conversion to monotherapy trial (SP902).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
322
Inclusion Criteria
  • Subject has entered the Maintenance Phase of the double-blind trial, SP902, (ie, has taken at least 1 dose of SP902 Maintenance Phase trial medication) and either completed SP902 or met an exit criterion in SP902; subject is allowed up to 2 concomitant Antiepileptic Drugs (AEDs)
Exclusion Criteria
  • Subject meets the withdrawal criteria (excluding exit criteria) for the SP902 trial, or is experiencing an ongoing Serious Adverse Event (SAE)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
LacosamideLacosamideLacosamide tablets for dosing 100 -800 mg/day
Primary Outcome Measures
NameTimeMethod
Percentage of Subjects on Lacosamide (LCM) Monotherapy at Any Time Between Visit 1 and End of StudyFrom Visit 1 to End of Study (approximately 2 years)

Percentage of Subjects on Lacosamide (LCM) Monotherapy at any time between Visit 1 and End of Study.

Duration of Lacosamide (LCM) Monotherapy Treatment From Visit 1 to End of StudyFrom Visit 1 to End of Study (approximately 2 years)

Duration of total Lacosamide Monotherapy From Visit 1 to End of Study.

Secondary Outcome Measures
NameTimeMethod
Occurrence of At Least One Treatment-Emergent Adverse Event (TEAE) From Visit 1 to End of StudyFrom Visit 1 to End of Study (approximately 2 years)

A TEAE is defined as any untoward medical occurrence (eg, noxious or pathological changes) in a subject or clinical investigation subject compared with pre-existing conditions, that occurs during any phase of a clinical trial including Pretreatment, Run-In, Wash-Out, or Follow-Up Phases.

An TEAE is defined as being independent of assumption of any causality (eg, to trial or concomitant medication, primary or concomitant disease, or trial design).

Occurrence of Treatment-Emergent Adverse Events (TEAE) Leading to Subject Withdrawal From Visit 1 to End of StudyFrom Visit 1 to End of Study (approximately 2 years)

Trial Locations

Locations (108)

137

🇺🇸

Waldorf, Maryland, United States

094

🇺🇸

Doral, Florida, United States

029

🇺🇸

Scarborough, Maine, United States

031

🇺🇸

Chesterfield, Missouri, United States

003

🇺🇸

Asheville, North Carolina, United States

015

🇺🇸

Cleveland, Ohio, United States

022

🇺🇸

Dallas, Texas, United States

024

🇺🇸

Beaufort, South Carolina, United States

078

🇺🇸

Indianapolis, Indiana, United States

051

🇺🇸

Houston, Texas, United States

160

🇺🇸

Wichita, Kansas, United States

284

🇵🇱

Czestochowa, Poland

290

🇵🇱

Lublin, Poland

009

🇺🇸

Phoenix, Arizona, United States

151

🇺🇸

Phoenix, Arizona, United States

147

🇺🇸

Oklahoma City, Oklahoma, United States

010

🇺🇸

Birmingham, Alabama, United States

425

🇦🇺

Chatswood, New South Wales, Australia

107

🇺🇸

Torrance, California, United States

421

🇦🇺

Capmerdown, New South Wales, Australia

423

🇦🇺

Herston, Queensland, Australia

004

🇺🇸

Tallahassee, Florida, United States

049

🇺🇸

Panama City, Florida, United States

023

🇺🇸

Wichita, Kansas, United States

083

🇺🇸

Buffalo, New York, United States

050

🇺🇸

Sarasota, Florida, United States

420

🇦🇺

Adelaide, South Australia, Australia

427

🇦🇺

Parkville, Victoria, Australia

369

🇬🇧

London, United Kingdom

058

🇺🇸

Boise, Idaho, United States

079

🇺🇸

Atlanta, Georgia, United States

041

🇺🇸

Detroit, Michigan, United States

011

🇺🇸

Springfield, Illinois, United States

124

🇺🇸

Manhattan, Kansas, United States

443

🇮🇹

Ferrara, Italy

113

🇨🇦

Montreal, Quebec, Canada

131

🇺🇸

Hines, Illinois, United States

280

🇵🇱

Krakow, Poland

065

🇺🇸

Pikesville, Maryland, United States

069

🇺🇸

Cedarhurst, New York, United States

066

🇺🇸

Saint Louis, Missouri, United States

071

🇺🇸

Hattiesburg, Mississippi, United States

461

🇩🇪

Mainz, Germany

067

🇺🇸

Voorhees, New Jersey, United States

447

🇮🇹

Torrette Di Ancona, Italy

117

🇺🇸

Wilmington, North Carolina, United States

360

🇬🇧

Blackpool, United Kingdom

289

🇵🇱

Szczecin, Poland

001

🇺🇸

Nashville, Tennessee, United States

053

🇺🇸

Houston, Texas, United States

042

🇺🇸

Northport, Alabama, United States

281

🇵🇱

Warszawa, Poland

014

🇺🇸

Phoenix, Arizona, United States

007

🇺🇸

Little Rock, Arkansas, United States

287

🇵🇱

Warszawa, Poland

161

🇺🇸

Alexandria, Virginia, United States

021

🇺🇸

Santa Monica, California, United States

363

🇬🇧

Middlesborough, United Kingdom

140

🇨🇦

Halifax, Nova Scotia, Canada

110

🇨🇦

Montreal, Quebec, Canada

127

🇨🇦

Calgary, Canada

122

🇺🇸

New York, New York, United States

048

🇺🇸

Alabaster, Alabama, United States

103

🇺🇸

Tucson, Arizona, United States

120

🇺🇸

La Habra, California, United States

086

🇺🇸

Little Rock, Arkansas, United States

059

🇺🇸

Los Angeles, California, United States

025

🇺🇸

Fairfield, Connecticut, United States

123

🇺🇸

Miami, Florida, United States

108

🇺🇸

Gainesville, Florida, United States

132

🇺🇸

Miami, Florida, United States

077

🇺🇸

Orlando, Florida, United States

129

🇺🇸

Port Charlotte, Florida, United States

073

🇺🇸

Ames, Iowa, United States

020

🇺🇸

Baltimore, Maryland, United States

034

🇺🇸

Baltimore, Maryland, United States

030

🇺🇸

Golden Valley, Minnesota, United States

017

🇺🇸

Lebanon, New Hampshire, United States

036

🇺🇸

Albany, New York, United States

027

🇺🇸

New York, New York, United States

063

🇺🇸

Durham, North Carolina, United States

061

🇺🇸

Columbus, Ohio, United States

100

🇺🇸

Greensburg, Pennsylvania, United States

114

🇺🇸

Chattanooga, Tennessee, United States

136

🇺🇸

Layton, Utah, United States

138

🇺🇸

Austin, Texas, United States

098

🇺🇸

San Antonio, Texas, United States

046

🇺🇸

El Paso, Texas, United States

016

🇺🇸

Charlottesville, Virginia, United States

080

🇺🇸

Madison, Wisconsin, United States

074

🇺🇸

Renton, Washington, United States

091

🇨🇦

Greenfield Park, Quebec, Canada

223

🇩🇰

Aarhus, Denmark

445

🇮🇹

Reggio Calabria, Italy

286

🇵🇱

Gdansk, Poland

282

🇵🇱

Gdynia, Poland

324

🇪🇸

Santa Cruz de Tenerife, Spain

364

🇬🇧

London, United Kingdom

367

🇬🇧

Cornwall, United Kingdom

002

🇺🇸

Toledo, Ohio, United States

146

🇺🇸

Peoria, Illinois, United States

102

🇺🇸

Jonesboro, Arkansas, United States

116

🇨🇦

Hamilton, Ontario, Canada

032

🇺🇸

Philadelphia, Pennsylvania, United States

093

🇨🇦

London, Ontario, Canada

060

🇺🇸

Aurora, Colorado, United States

062

🇺🇸

Louisville, Kentucky, United States

164

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath